| Literature DB >> 35800626 |
Taher Babaee1, Vahideh Moradi2, Ardalan Shariat3, Albert T Anastasio4, Alireza Khani5, Mahtab Bagheri1, Naeimeh Rouhani1.
Abstract
Adolescent idiopathic scoliosis (AIS) and Scheuermann's kyphosis (SK) are the most common types of spinal deformities in adolescents, and both have substantial ramifications on health-related quality of life (HRQoL) parameters. Various questionnaires have been developed to assess HRQoL in age-group populations with spinal deformity. Nevertheless, there remains a lack of consensus across the literature as to which instrument is the most suitable for evaluating the HRQoL of this cohort. Thus, this literature review was conducted to present disease-specific questionnaires for children and adolescents with AIS and SK to provide their psychometric characteristics (validity, reliability, and responsiveness) across different languages. A literature search was performed in the Medline (PubMed), Scopus, EMBASE, and Google Scholar databases. Studies that outlined the development and application of questionnaires evaluating HRQoL of children and adolescents with spinal deformity were included, and data on their validity and reliability in different translated languages were collected. A total of 10 disease-specific questionnaires were identified. Except for one questionnaire that was a proxy-reported measure, the other questionnaires were self-reported. We determined that selecting the proper questionnaire for clinical and research purposes requires careful consideration of various factors including the type of treatment intervention planned as well as various patient demographic factors. For children with early-onset scoliosis, the ideal questionnaire to evaluate their HRQoL is the Early-Onset Scoliosis Questionnaire-24. For adolescents with AIS and SK who are potential candidates for surgical intervention, the use of Scoliosis Research Society-22, Scoliosis Japanese-27, and Quality of Life Profile Spinal Deformity questionnaires is appropriate. For patients who are under nonsurgical treatment, the Brace Questionnaire and Italian Spine Youth Quality of Life questionnaires can be utilized. Nonetheless, when the specific intent of a study is to evaluate the self-image perception of patients, the use of drawing-based questionnaires may be the optimal choice.Entities:
Keywords: Adolescent idiopathic scoliosis; Quality of life; Questionnaire; Scheuermann Disease
Year: 2022 PMID: 35800626 PMCID: PMC9200414 DOI: 10.22603/ssrr.2021-0237
Source DB: PubMed Journal: Spine Surg Relat Res ISSN: 2432-261X
Results of Validity and Reliability of the QLPSD in Different Studies.
| References | No. of patients | Age (years) | Intervention | Internal consistency | Test–retest reliability | Test time intervals | Convergent validity | Discriminate validity | Responsiveness | Floor effect (%) | Ceiling effect (%) | Missing answer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rezaei Motlagh et al. (Persian version) | 105 | 10–19 | Brace | Psychosocial
| Psychosocial
| 2 weeks | Pearson r=0.30–0.62 with SRS-22 | Able to discriminate between participants who differed regarding the type of deformity, gender, Cobb angle, and duration of bracing | Not provided | Not provided | Not provided | Not provided |
| Climent et al. (Original Spanish version) | 174 | 15 | Not provided | Psychosocial
| Psychosocial
| 10 days | Pearson r=0.22–0.38 with SRS-22 | Able to discriminate between participants regarding the type of curve, back pain, and type of treatment. | Not provided | Not provided | Not provided | Not provided |
| Korovessis et al. (Greece version) | 79 | 12.7 | Brace | Not provided | Psychosocial
| 4 weeks | Not provided | Able to discriminate between participants regarding the type of deformity. | Not provided | Not provided | Not provided | Not provided |
| Schulte et al. (German version) | 255 | 16 | Brace surgery | Psychosocial
| Psychosocial
| 8 weeks | Pearson r=0.32–0.59 with SRS-22 | Able to distinguish between patients with scoliosis and individuals in a healthy control group and patients with different curve magnitude. | Not provided | Not provided | Not provided | Not provided |
Results of Validity and Reliability of the SRS-22 in Different Studies.
| References | No. of patients | Age (years) | Intervention | Internal consistency | Test–retest reliability | Test time intervals | Convergent validity | Discriminate validity | Responsiveness | Floor effect (%) | Ceiling effect (%) | Missing answer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asher et al. (Original English version) | 58 | 14.6 | Surgery | Function: 0.86
| Function: 0.90
| 28 | Pearson r=0.68–0.90 with SF-36 | Not provided | Not provided | <2% | 15.5% for mental health, 20.7% for pain, and 56.9% for satisfaction domains | Not provided |
| Asher et al. (Original English version) | 100 | 13–14 | Untreated (n=54)
| Not provided | Not provided | Not provided | Not provided | Able to discriminate between individuals with no scoliosis or moderate curves and large curves. It cannot discriminate patients regarding curve type. Severity of trunk asymmetry was significantly correlated with self-image, function, and pain scores. | Not provided | Not provided | Not provided | Not provided |
| Asher et al. (Original English version) | 58 | 16 | Surgery | Not provided | Not provided | Preoperatively, at 3, 6, 12, and 24 month intervals postoperatively | Not provided | Not provided | Self-image was made better after 3 months ( | Not provided | Not provided | Not provided |
| Alanay et al. (Turkish version) | 54 | 19.8 | Surgery | Function: 0.81
| Function: 0.76
| 35 days | Pearson r=0.27–0.81 with SF-36 | Not provided | Not provided | <7% | 17% for pain and 55.3% for satisfaction domains | Not provided |
| Lonjon et al. (French–Canadian version in France) | 145 | 14.2 | Surgery
| Function: 0.68
| Not provided | Not provided | Pearson r=0.54–0.79 with SF-12 | Able to discriminate AIS cases regarding sex, age, BMI, curve magnitude, and treatment types. | Not provided | <1% | 22.1% for pain and satisfaction domains | Not provided |
| Sathira-Angkura et al. (Thai version) | 58 | 18.7 | Surgery | Function: 0.70
| Function: 0.79
| 14 days | Pearson r=0.73 with SF-36 | Not provided | Not provided | <2% | 6.9% for mental health, 13.8% for pain, and 43.1 for satisfaction domains | Not provided |
| Lee et al. (Korean version) | 64 | 18.3 | Surgery | Function: 0.85
| Function: 0.83
| Not provided | Pearson r=0.19–0.81 with SF-36 | Not provided | Not provided | Function: 1.2
| Function: 31.3
| Not provided |
| Théroux et al. (French version) | 352 | 13.5 | Brace | Pain: 0.79
| Not provided | Not provided | Pearson r=0.36–1.00 with SF-12 | Not provided | Not provided | <2% | 11.1% for mental health, 22.8% for pain, and 17.1 for satisfaction domains | Not provided |
| Cheung et al. (Chinese version) | 48 | 16.5 | Not provided | Function: 0.86
| Function: 0.83
| 7 days | Pearson r=0.18–0.77 with SF-36 | Not provided | Not provided | <7% | 18% for mental health, 30% for pain, and 44% for function | Not provided |
| Climent et al. (Spanish version) | 175 | 19 | Brace
| Not provided | Not provided | Not provided | Pearson r=0.84 with QLPSD | Able to discriminate AIS cases regarding age, curve magnitude, and treatment types. | Not provided | Not provided | Not provided | Not provided |
| Simony et al. (Danish version) | 169 | Not provided | Brace
| Function: 0.89
| Not provided | Not provided | Pearson r=0.62 with SF-36 | Not provided | Not provided | <2% | 25.45% for function 9.09% for pain, and 26.42 for satisfaction domains | Not provided |
| Danielsson et al. (Swedish version) | 141 | 23.3 | Brace
| Function: 0.72
| Function: 0.87
| 2 weeks | Pearson r=0.08–0.88 with SF-36 | Able to discriminate AIS cases regarding age, curve magnitude, and treatment types. | Not provided | <3% | 22.8% for function 28.3% for pain, and 17.7% for satisfaction domains | Not provided |
| Mousavi et al. (Persian version) | 84 | 12–18 | Brace
| Function: 0.70
| Function: 0.87
| 1–2 weeks | Pearson r=0.35–0.85 with SF-36 | Able to discriminate cases regarding curve magnitude, and function. | Not provided | <3% | 16.1% for pain and 19.4% for satisfaction domains | Not provided |
| Schlösser et al. (Dutch version) | 135 | 15.1 | Brace
| Function: 0.74
| Function: 0.86
| 2 weeks | Pearson r=0.38–0.88 with SF-36 | Able to discriminate between scoliosis patients with different levels of disease-specific quality of life | Not provided | <2% | 33% for function 20% for pain and 22% for satisfaction domains | Not provided |
| Haidar et al. (Arabic version) | 81 | 10–18 | Brace
| Function: 0.58
| Function: 0.87
| 1 week | Not provided | Not provided | Not provided | <5% | 14.6% for pain and 26.8% for satisfaction domains | Not provided |
| Glowacki et al. (Polish version) | 60 | 16.6 | Surgery | Function: 081
| Function: 0.58
| 1 day | Not provided | Not provided | Not provided | <2% | 36% for pain and 15% for mental health and 38% for function domains | Not provided |
| Hashimoto et al. (Japanese version) | 114 | 10–18 | Not provided | Function: 0.75
| Not provided | Not provided | Pearson r=0.18–0.80 with SF-36 | Able to discriminate cases regarding curve magnitude, and pattern plus treatment. | Not provided | Not provided | 38% for function, 36% for pain and 15% for mental health domains | Not provided |
| Monticone et al. (Italian version) | 35 | 8.5–19 | Brace
| Not provided | Not provided for each domain | 1 week | Not provided | Not provided | Not provided | <2% | 15.5% for mental health 20.7% for pain and 56.9% for satisfaction domains | Not provided |
| Niemeyer et al. (German version) | 222 | 19 | Brace
| Function: 0.67
| Function: 0.80
| 30 days | Spearman rho
| Not provided | Not provided | 0.0% | 11.5% for mental health 17.9% for pain, and 26.9% for satisfaction domains | Not provided |
| Zhao et al. (Chinese version) | 86 | 13.9 | Brace | Function: 0.70
| Function: 0.85
| 3-4 days | Function: 0.66–0.74
| Not provided | Not provided | Pain: 7.0
| Pain 15.7 | Not provided |
| Li et al. (simplified Chinese (mainland) version) | 87 | 15.6 | Surgery | Function: 0.81
| Function: 0.74
| 21 day | Pearson r=−0.25–1.0 with SF-36 | Not provided | Not provided | 1.6%–3.2% | 1.6% for self-image to 22.2% for pain. | Not provided |
| Bezale et al. (Hebrew version) | 45 | 17.3 | Brace
| Function: 0.63
| Function: 0.88
| Not provided | Pearson r=0.22–0.54 with SF-36 | Not provided | Not provided | 15.0% for function. 18.3% for pain and 26.7% for satisfaction domains | <4% | Not provided |
| Beause´jour et al. (French– Canadian versions) | 145 | 9.8–21.2 | Brace
| Function: 0.67
| Not provided | Not provided | Pearson r=0.54–0.79 with SF-12 | Able to discriminate AIS cases according to gender, age, BMI, main curve type, and curve size. | Not provided | 0.0%–0.7% | Pain: 22.1%
| Not provided |
| Antonarakos et al. (Greek version) | 51 | 21.2 | Surgery | Function: 0.67
| >0.70 for all domains | Not provided | Pearson r=0.38–0.89 with SF-36 | Not provided | Not provided | 2.00% | Satisfaction: 37.3% | Not provided |
Results of Validity and Reliability of the BrQ in Different Studies.
| References | No. of patients | Age (years) | Intervention | Internal consistency | Test–retest reliability | Test time intervals | Convergent validity | Discriminate validity | Responsiveness | Floor effect (%) | Ceiling effect (%) | Missing answer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rezaee et al. (Persian version) | 51 | 13.88±2.14 | Brace | General health perception: 0.72
| General health perception: 0.96
| 7 days | Pearson r=0.17–0.71 with SRS-22 | Not provided | Not provided | 0% | 0% | Not provided |
| Vasiliadis et al. (Greek version) | 28 | 13.5 | Brace | General health perception: 0.72
| Not provided | Not provided | Not provided | The correlation between BrQ overall scores for mild (18°–29°) and moderate (30°–38°) scoliosis was statistically significant | The BrQ is responsive to clinician-rated changes in health status. | 0% | 0.0%–10.7% | 0.0%–3.57% |
| Chan et al. (Chinese version) | 120 | 9–18 | Brace | General health perception: 0.70
| 0.83 | 1–2 weeks | Pearson r=0.07–0.18 with SRS-22 | Able to discriminate cases regarding the time of wearing and age | Not provided | 0.0%–12.1% | 17.2% for school activity
| 0% |
| Deceuninck et al. (French version) | 40 | 9–17 | Brace | 0.85 | 0.79 | 7 days | Not provided | Not provided | Not provided | 0.0%–2.5% | 0.0%–15% | Not provided |
| Kinel et al. (Polish version) | 35 | 10–16 | Brace | General health perception: 0.51
| 0.82 | 7 days | Not provided | Not provided | Not provided | 0% | 17% for item 21 to 33% for item 6. | Not provided |
| Aulisa et al. (Italian version) | 34 | 14 | Brace | Not provided | 0.94 | 3–7 days | Pearson r=0.38–0.82 with SRS-22 | Able to discriminate cases regarding Cobb angle age | Not provided | Not provided | Not provided | Not provided |
| Gür et al. (Turkish version) | 28 | 14.6 | Brace | 0.94 | General health: 0.72
| 5 days | Pearson r=0.67 and 0.64 with BSSQ-Brace and SRS-22, respectively. | Not provided | Not provided | Not provided | Not provided | Not provided |
| Lim et al. (Korean version) | 120 | 12.1 | Brace | General health: 0.88
| General health: 0.90
| 1 or 2 weeks | Pearson r=0.71 with SRS-22 | Able to discriminate patients according to curve magnitude | Not provided | No floor effects | No ceiling effects | Not provided |
Results of Validity and Reliability of the SAQ in Different Studies.
| References | No. of patients | Age (years) | Intervention | Internal consistency | Test–retest reliability | Test time intervals | Convergent validity | Discriminate validity | Responsiveness | Floor effect (%) | Ceiling effect (%) | Missing answer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roy–Beaudry et al. (French–Canadian Version) | 182 | Not provided | Brace surgery | General: 0.33–0.660
| Not provided | Not provided | Pearson r=0.35–0.53 with SRS-22 | The SAQ can discriminate between relevant clinical values of scoliosis severity | Not provided | 15.4% for chest domain | 34.6% for mental health
| Not provided |
| Guo et al. (traditional Chinese version) | 112 | 13 | Brace
| General: 0.66
| General: 0.86
| 2 weeks | Pearson r=0.15–0.44 with SRS-22 | TC-SAQ total score was significantly positively correlated to major curve magnitude. | Not provided | for the prominence (15.2%) and kyphosis (22.3%) | For waist (26.8%) and chest (33.0%) | Not provided |
| Carreon et al. (Original English version) | 1802 | 14.8 | Brace
| Appearance: 0.89
| Appearance: 0.81
| 2 weeks | 0.16–0.50 | It discriminates between patients who require surgery from those who do not. | Not provided | 0.0% | 0.0% | Not provided |
| Lee et al. (Korean version) | 160 | 12.3 | Brace
| General: 0.892
| General: 0.922
| 2 weeks | Pearson r=0.35–0.53 with SRS-22 | It discriminates among patients requiring observation, bracing, or surgery. | Not provided | 14.2 for curve and 15.2 for kyphosis | 10.7 for curve and 17.9 for waist and 18.8 for chest | Not provided |
| Sanders et al. (Original English version) | 127 | Not provided | Brace
| >0.7 | 0.57–0.99 | 1–47 days | Not provided | Not provided | The SAQ demonstrates excellent responsiveness to surgical curve correction and excellent responsiveness to surgical correction. | Not provided | Not provided | Not provided |
| Simony et al. (Danish version) | 51 | 16 | Brace
| Appearance: 0.93
| Appearance: 086
| 2 weeks | Pearson r=−0.24 to −0.60 with SRS-22 | It can discriminate between the patients who require surgery from those who do not have surgery and significantly correlated with curve magnitude. | Not provided | 7.84% for Expectations | 17.65% for Expectations | Not provided |
| Yapar et al. (Turkish version) | 75 | 15.5 | Brace
| Appearance: 0.94
| Appearance: 0.97
| 14–28 days | Spearman rho
| There were strong positive correlations between the patient’s major curve magnitude and appearance score and total score in Tr-SAQ. | Not provided | 0.0% | 37.3% for Expectations | Not provided |
| de Albuquerque Rosendo et al. (Brazilian Portuguese) | 20 | 14.8 | Surgery | 0.79 for patients and 0.75 for their relatives | Not provided | Not provided | Not provided | Not provided | Not provided | Not provided | Not provided | Not provided |
| Wei et al. (Simplified Chinese) | 223 | 14.58 | Brace
| General: 0.55–0.75
| 0.90–0.95 | 4–7 days | Pearson r=−0.35 to −0.53 with SRS-22 | Able to discriminate cases regarding curve magnitude and pattern plus treatment. | Not provided | 15.3% for curve and 16.7% for kyphosis | 19.5% for waist and 20.5% for chest | Not provided |
Results of Validity and Reliability of the EOSQ-24 in Different Studies.
| References | No. of patients | Age (years) | Intervention | Internal consistency | Test–retest reliability | Test time intervals | Convergent validity | Discriminate validity | Responsiveness | Floor effect (%) | Ceiling effect (%) | Missing answer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Matsumoto et al. (Original English version) | 90 | 6.4 | Surgery | General Health, Pain/Discomfort, Pulmonary Function, Transfer, Physical Function, Daily Living Fatigue/Energy Level, and Emotion=0.92;
| General Health (0.84), Pain/Discomfort (0.85), Pulmonary Function (0.90), Transfer (0.84), Physical Function (0.97), Daily Living (0.98), Fatigue/Energy Level (0.92), Financial Burden (0.94), Child Satisfaction (0.93), and Parent Satisfaction (0.89). Emotion (0.68) and Parental Burden (0.80) | 7–29 days | The EOSQ-24 domain scores of General Health, Pain/Discomfort, Pulmonary Function, Physical Function, Daily Living, Fatigue/Energy Level, and Emotion were positively correlated with % predicted values of forced expiratory volume in 1 second and forced vital capacity. | The EOSQ-24 scores could discriminate patients with different etiology. | There were significant differences between preoperative and postoperative scores of EOSQ-24. | Not provided | Not provided | Not provided |
| del Mar Pozo-Balado et al. (Spanish version) | 44 | <10 | Observation
| General health: 0.82
| Not provided | Not provided | Not provided | It can discriminate between
| Not provided | The floor effect ranged from 22.7% for item 11 to 29.5% for item 12. | The ceiling effect ranged from 19.7% for item 21 to 74.4% for item 5. | 0%–6.8% |
| Molland et al. (Norwegian version) | 100 | 8.9 | Surgery graduated
| General health: 0.78
| General health: 0.84
| 2 weeks | High correlations were found between the EOSQ-24 total score and NRS general health (r=0.66), NRS pain (r=0.63), and NRS physical function (r=0.78) ( | It has discriminate capabilities among patients with different etiology, treatment status, and severity of deformity | Not provided | The floor effect ranged from 17% for item 9 to 26% for item 12. | The ceiling effect ranged from 19% for item 2 to 63% for item 5. | 0%–3%. |
| Demirkiran et al. (Turkish version) | 61 | 9.1 | Surgery | General Health: 0.42
| Not provided | Not provided | Pearson r=0.051–0.523 with Child Health Questionnaire–Parental Form-50 | Not provided | Not provided | The floor effect ranged from 16.4% for items 19 and 22 to 21.7% for item 10. | The ceiling effect ranged from 18.6% for item 2 to 68.3% for item 6. | Pain: 3.3
|
| Wijdicks et al. (Dutch version) | 103 | 9.1 | Brace
| General health: 0.59
| General health: 0.89
| 4 months | Pearson r=−0.35 to −0.76 with SRS-22 | Able to discriminate between scoliosis type, curve severity, and ambulatory status | Not provided | The floor effect ranged from 17.5% for item 11 to 28.2% for item 12. | The ceiling effect ranged from 16.5% for item 1 to 72.8% for item 5. | 1% |
| Cheung et al. (Traditional Chinese) | 100 | 12.1 | Observation only
| General health: 0.91
| Not provided | Not provided | The total score of EOSQ-24 had significant correlations ( | The EOSQ-24 was able to detect statistical differences in its total score between patients who were ambulatory versus those who were nonambulatory, as well as between EOS patients of various etiologies. There were statistically significant differences in the domain Family Burden and subdomain Emotion and Financial Burden for patients undergoing bracing as compared with those who had surgery | Not provided | Item 8: 16%
| The ceiling effect ranged from 4% for item 1 to 71% for item 5. | 0% |
| De Mendonc et al. (Brazilian Portuguese) | 76 | 11.88 | Not provided | General health: 0.81
| Not provided | Not provided | Not provided | Items correlation presented good discriminatory validity for all domains. | Not provided | Item 9: 28.9%
| The ceiling effect ranged from 3.9% for item 2 and 42.1% for item 18. | 0% |
| Hanbali et al. (Arabic version) | 58 | <10 | Surgery | General health: 91
| Not provided | Not provided | Not provided | Able to discriminate patients according to severity of curves, complications after surgery, and ambulatory status. | Not provided | Item 17: 36.2%
| 0.0% for item 21 and 46.6% for item 5. | 1.7% |
| Esfandiari et al. (Persian version) | 100 | 6.30 | Brace
| General health: 0.69
| Not provided | Not provided | Pearson r=0.44–0.67 with SRS-22 | Able to discriminate cases regarding curve magnitude | Not provided | No significant floor effect was observed. | The ceiling effect ranged from 8% for item 23 to 52% for item 2. | <1% |
EOSQ-24=Early-Onset Scoliosis 24-item Questionnaire, NRS=numeric rating scale
Results of Validity and Reliability of the BSSQ in Different Studies.
| References | No. of patients | Age (years) | Intervention | Internal consistency | Test–retest reliability | Test time intervals | Convergent validity | Discriminate validity | Responsiveness | Floor effect (%) | Ceiling effect (%) | Missing answer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Botens-Helmus et al. (BSSQ-brace, original German version) | 62 | 14.5 | Brace | 0.97 | 0.88 | 1–3 days | Not provided | Not provided | Not provided | 2.3% | 27% | Not provided |
| D’Agata et al. (Spanish version) | 35 | 13 | Brace | 0.80 | 0.90 | 4–7 days | Pearson r=0.65 with SRS-22 | Not provided | Not provided | 0% | 0% | Not provided |
| Misterska et al. (Polish version) | 35 | 14.8 | Brace | BSSQ-Deformity: 0.87; BSSQ-Brace: 0.80 | BSSQ-Deformity: 0.95; BSSQ-Brace: 0.88 | 2 days | Not provided | Significant correlation was identified between BSSQ-Brace and the angle of rotation (r=0.395). | Not provided | 2.9% | 17.1% | Not provided |
| Asada et al. (Japanese version) | 71 | 14 | Brace | 0.84-0.87 | 0.75 | 7 days | Not provided | Not provided | Not provided | 0% | 6.8%–13.6% | Not provided |
| Xu et al. (Chinese version) | 50 | 13 | Brace | BSSQ-Brace: 80; BSSQ-Deformity: 85 | BSSQ-Brace: 0.90; BSSQ-Deformity: 0.85 | 3–7 days | Pearson r=0.29–0.79 | Not provided | Not provided | <5% | <5% | Not provided |
| Rezaei Motlagh et al. (Persian version) | 53 | 13.47 | Brace | BSSQ-Brace: 0.72; BSSQ-Deformity: 0.72 | BSSQ-Brace: 0.88; BSSQ-Deformity: 0.97 | 2 weeks | Spearman r=0.34–0.63 with SRS-22 | Not provided | Not provided | Not provided | Not provided | Not provided |
| Aulisa et al. (Italian version) | 108 | 15.4 | Brace | 0.91 | Pearson r=0.92 | 5–7 days | Pearson r=0.39 with SRS-22 | Not provided | Not provided | Not provided | Not provided | Not provided |
Results of Validity and Reliability of the BIDQ, the SRS-7, the ISYQOL, and the TAPS in Different Studies.
| Questionnaire | References | No. of patients | Age (years) | Intervention | Internal consistency | Test–retest reliability | Test time intervals | Convergent validity | Discriminate validity | Responsiveness | Floor effect (%) | Ceiling effect (%) | Missing answer (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| The BIDQ | Auerbach et al. (Original English version) | 98 | 15.7 | Surgery | 0.82 | Not provided | Not provided | Pearson r=−0.50 to −0.72 with SRS-22 | BIDQ-S scores differed significantly between patients and controls, establishing discriminant validity. | Not provided | Not provided | Not provided | Not provided |
| Wetterkamp et al. (German version) | 259 | 30.2 | Brace
| 0.87 | 0.79 | 8 weeks | r=−0.30 to −0.72 with SRS-22 | The German-BIDQ showed discriminant validity, with a strong difference between the scoliosis group and the control group. | Not provided | Not provided | Not provided | Not provided | |
| Bae et al. (Korean version) | 152 | 12.5 | Brace
| Question 1: 0.88
| Question 1: 0.90
| 2 weeks | Pearson r=0.617 with Spinal Appearance Questionnaire | Discriminant validity was confirmed by significant differences in K-BIDQ scores among patients requiring observation, bracing, or surgery. | Not provided | 0% | 0% | Not provided | |
| Bao et al. (Simplified Chinese version) | 100 | 10.5 | Brace
| Question 1: 0.85
| Not provided | Not provided | Pearson r=−0.32 to −0.65 with SRS-22 and Pearson r=0.24 to 0.67 with Spinal Appearance Questionnaire | Discriminant validity was confirmed by significant differences in BIDQ scores among patients with different Cobb angles. | Not provided | Not provided | Not provided | Not provided | |
| Kuzu et al. (Turkish version) | 83 | 14–69 | Observation
| 0.88 | Not provided | Not provided | Pearson r=0.69 with total score of the SRS-22 | Not provided | Not provided | Not provided | Not provided | Not provided | |
| The SRS-7 | Jain et al. | 685 | 14.7 | Surgery | 0.64 for preoperative patients and 0.67 for postoperative patients | Not provided | Not provided | There was a strong correlation between preoperative SRS-7 and SRS-22 scores (r=0.78; | Discriminant validity was confirmed by significant differences in SRS-7 scores among patients with different Cobb angles. | The SRS-7 was very effective in terms of detecting a change in HRQOL measures with surgical treatment in children with AIS. | Not provided | Not provided | Not provided |
| The ISYQOL | Caronni et al. (Original Italian version) | 1000 | 16 | Observation
| Not provided | Not provided | Not provided | Satisfactory correlations were found between ISYQOL and SRS22 (scoliosis, rho=0.71; kyphosis, rho=0.56). | The ISYQOL can discriminate across groups of patients regarding diagnosis, sex, age, curve magnitude, and treatment types. | Not provided | Not provided | Not provided | Not provided |
| Kinel et al. (Polish version) | 58 | 13.8 | Brace | Spine health: 0.79
| 0.90 | 7 days | Not provided | Not provided | Not provided | 0% | 0.0%–1.7% | Not provided | |
| Liu et al. (simplified Chinese) | 138 | 13.7 | Observation
| Spine health: 0.85
| 0.72–0.80 | 14 days | Spearman rho=0.62 with SRS-22 | Not provided | Not provided | 0% | 0% | 0.6 | |
| Scoliosis Japanese Questionnaire- 27 | Doi et al. (Original Japanese version) | 384 | 14.3 | Brace
| 0.91 | Not provided | Not provided | Spearman rho=0.69 with SRS-22 | Not provided | Not provided | 0.5% | 0% | 0.1% |
| Bazancir et al. (Turkish version) | 139 | 0.99 | 0.99 | Pearson r=0.61 with SRS-22 | |||||||||
| Trunk Appearance Perception Scale (TAPS) | Bago et al. (Original version) | 186 | 17.8 | Observation
| 0.89 | 0.92 | 7 days | Spearman rho=0.47–0.52 | The TAPS can discriminate across groups of patients regarding curve type and curve magnitude. | The TAPS instrument shows adequate responsiveness to surgical treatment of idiopathic scoliosis. | 1.6% | 3.8% | 0% |
| Misterska et al. (Polish version) | 36 | 13.4 | Brace | 0.50–0.84 | Not provided | Not provided | Spearman rho=−0.44 with Cobb angle | Not provided | Not provided | 0.0% | 2.7% | Not provided |